A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator

A life-long bleeding disorder is described, characterized by hemorrhage occurring after surgery, injury, or dental extraction, and finally by spontaneous intracerebral bleeding. No abnormality of platelet function or plasma coagulation was demonstrable, but grossly enhanced overall fibrinolytic acti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 1983-02, Vol.61 (2), p.267-275
Hauptverfasser: Booth, N.A., Bennett, B., Wijngaards, G., Grieve, J.H.K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 275
container_issue 2
container_start_page 267
container_title Blood
container_volume 61
creator Booth, N.A.
Bennett, B.
Wijngaards, G.
Grieve, J.H.K.
description A life-long bleeding disorder is described, characterized by hemorrhage occurring after surgery, injury, or dental extraction, and finally by spontaneous intracerebral bleeding. No abnormality of platelet function or plasma coagulation was demonstrable, but grossly enhanced overall fibrinolytic activity was present. The patient had, additionally, a hyperlipidemia with gross arterial atheroma and a family history of myocardial infarction but not of any hemorrhagic disorder. Laboratory studies led to the conclusion that the enhanced fibrinolysis was due to consistently greatly raised levels of a plasma plasminogen activator physically and immunologically related to that in human tissues and blood vessel endothelium. No deficiency of any known inhibitor of fibrinolysis was detected. Free plasmin was not detectable in functional assays but continuous intravascular plasmin generation clearly occurred as evidenced by presence of plasmin-α2-antiplasmin complexes and of fibrin/fibrinogen-related antigens. Excessive production of plasminogen activator appeared to have occurred throughout life and to be independent of the hyperlipidemia. The pathologically increased fibrinolytic activity may have accounted for the complete absence of detectable thrombotic vascular occlusion at autopsy despite extensive arterial disease with severe narrowing of coronary and cerebral arteries.
doi_str_mv 10.1182/blood.V61.2.267.267
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80355400</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120809264</els_id><sourcerecordid>80355400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-2a0a57fd8b66764fb28116118605c97518f74acbed451c6242a10a73e7f5b7b63</originalsourceid><addsrcrecordid>eNp9kD9PwzAUxC0EKqXwCRCSJ7YU24n_dGCoaKFIFTAAq-U4L8UoiYudFPj2pLRiZDi94d2ddD-EzikZU6rYVV55X4xfBR2zMRNyqwM0pJyphBBGDtGQECKSbCLpMTqJ8Z0QmqWMD9BACEW5UkO0mOIH-MRLV0Ky9M0KL6D2IbyZlbN45qIPBQQ86wC3Hs-_LMSInyoTa9f4FTR4alu3Ma0Pp-ioNFWEs_0doZfb-fPNIlk-3t3fTJeJTSeTNmGGGC7LQuVCSJGVOVOUin6OINxOJKeqlJmxORQZp1awjBlKjExBljyXuUhH6HLXuw7-o4PY6tpFC1VlGvBd1IqknGeE9MZ0Z7TBxxig1OvgahO-NSV6y0__8tM9P810z26rPnWxr-_yGoq_zB5Y_7_e_aHfuHEQdLQOGguFC2BbXXj3b_8Pw-GAiA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80355400</pqid></control><display><type>article</type><title>A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Booth, N.A. ; Bennett, B. ; Wijngaards, G. ; Grieve, J.H.K.</creator><creatorcontrib>Booth, N.A. ; Bennett, B. ; Wijngaards, G. ; Grieve, J.H.K.</creatorcontrib><description>A life-long bleeding disorder is described, characterized by hemorrhage occurring after surgery, injury, or dental extraction, and finally by spontaneous intracerebral bleeding. No abnormality of platelet function or plasma coagulation was demonstrable, but grossly enhanced overall fibrinolytic activity was present. The patient had, additionally, a hyperlipidemia with gross arterial atheroma and a family history of myocardial infarction but not of any hemorrhagic disorder. Laboratory studies led to the conclusion that the enhanced fibrinolysis was due to consistently greatly raised levels of a plasma plasminogen activator physically and immunologically related to that in human tissues and blood vessel endothelium. No deficiency of any known inhibitor of fibrinolysis was detected. Free plasmin was not detectable in functional assays but continuous intravascular plasmin generation clearly occurred as evidenced by presence of plasmin-α2-antiplasmin complexes and of fibrin/fibrinogen-related antigens. Excessive production of plasminogen activator appeared to have occurred throughout life and to be independent of the hyperlipidemia. The pathologically increased fibrinolytic activity may have accounted for the complete absence of detectable thrombotic vascular occlusion at autopsy despite extensive arterial disease with severe narrowing of coronary and cerebral arteries.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood.V61.2.267.267</identifier><identifier>PMID: 6681588</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>alpha-2-Antiplasmin - immunology ; Blood Coagulation Tests ; Cerebral Hemorrhage - complications ; Fibrinolysis ; Hematoma - etiology ; Hemorrhagic Disorders - complications ; Hemorrhagic Disorders - etiology ; Humans ; Hyperlipidemias - complications ; Hyperlipidemias - genetics ; Immunoelectrophoresis ; Male ; Middle Aged ; Plasminogen Activators - biosynthesis</subject><ispartof>Blood, 1983-02, Vol.61 (2), p.267-275</ispartof><rights>1983 American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-2a0a57fd8b66764fb28116118605c97518f74acbed451c6242a10a73e7f5b7b63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6681588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Booth, N.A.</creatorcontrib><creatorcontrib>Bennett, B.</creatorcontrib><creatorcontrib>Wijngaards, G.</creatorcontrib><creatorcontrib>Grieve, J.H.K.</creatorcontrib><title>A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator</title><title>Blood</title><addtitle>Blood</addtitle><description>A life-long bleeding disorder is described, characterized by hemorrhage occurring after surgery, injury, or dental extraction, and finally by spontaneous intracerebral bleeding. No abnormality of platelet function or plasma coagulation was demonstrable, but grossly enhanced overall fibrinolytic activity was present. The patient had, additionally, a hyperlipidemia with gross arterial atheroma and a family history of myocardial infarction but not of any hemorrhagic disorder. Laboratory studies led to the conclusion that the enhanced fibrinolysis was due to consistently greatly raised levels of a plasma plasminogen activator physically and immunologically related to that in human tissues and blood vessel endothelium. No deficiency of any known inhibitor of fibrinolysis was detected. Free plasmin was not detectable in functional assays but continuous intravascular plasmin generation clearly occurred as evidenced by presence of plasmin-α2-antiplasmin complexes and of fibrin/fibrinogen-related antigens. Excessive production of plasminogen activator appeared to have occurred throughout life and to be independent of the hyperlipidemia. The pathologically increased fibrinolytic activity may have accounted for the complete absence of detectable thrombotic vascular occlusion at autopsy despite extensive arterial disease with severe narrowing of coronary and cerebral arteries.</description><subject>alpha-2-Antiplasmin - immunology</subject><subject>Blood Coagulation Tests</subject><subject>Cerebral Hemorrhage - complications</subject><subject>Fibrinolysis</subject><subject>Hematoma - etiology</subject><subject>Hemorrhagic Disorders - complications</subject><subject>Hemorrhagic Disorders - etiology</subject><subject>Humans</subject><subject>Hyperlipidemias - complications</subject><subject>Hyperlipidemias - genetics</subject><subject>Immunoelectrophoresis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Plasminogen Activators - biosynthesis</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD9PwzAUxC0EKqXwCRCSJ7YU24n_dGCoaKFIFTAAq-U4L8UoiYudFPj2pLRiZDi94d2ddD-EzikZU6rYVV55X4xfBR2zMRNyqwM0pJyphBBGDtGQECKSbCLpMTqJ8Z0QmqWMD9BACEW5UkO0mOIH-MRLV0Ky9M0KL6D2IbyZlbN45qIPBQQ86wC3Hs-_LMSInyoTa9f4FTR4alu3Ma0Pp-ioNFWEs_0doZfb-fPNIlk-3t3fTJeJTSeTNmGGGC7LQuVCSJGVOVOUin6OINxOJKeqlJmxORQZp1awjBlKjExBljyXuUhH6HLXuw7-o4PY6tpFC1VlGvBd1IqknGeE9MZ0Z7TBxxig1OvgahO-NSV6y0__8tM9P810z26rPnWxr-_yGoq_zB5Y_7_e_aHfuHEQdLQOGguFC2BbXXj3b_8Pw-GAiA</recordid><startdate>198302</startdate><enddate>198302</enddate><creator>Booth, N.A.</creator><creator>Bennett, B.</creator><creator>Wijngaards, G.</creator><creator>Grieve, J.H.K.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198302</creationdate><title>A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator</title><author>Booth, N.A. ; Bennett, B. ; Wijngaards, G. ; Grieve, J.H.K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-2a0a57fd8b66764fb28116118605c97518f74acbed451c6242a10a73e7f5b7b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>alpha-2-Antiplasmin - immunology</topic><topic>Blood Coagulation Tests</topic><topic>Cerebral Hemorrhage - complications</topic><topic>Fibrinolysis</topic><topic>Hematoma - etiology</topic><topic>Hemorrhagic Disorders - complications</topic><topic>Hemorrhagic Disorders - etiology</topic><topic>Humans</topic><topic>Hyperlipidemias - complications</topic><topic>Hyperlipidemias - genetics</topic><topic>Immunoelectrophoresis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Plasminogen Activators - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Booth, N.A.</creatorcontrib><creatorcontrib>Bennett, B.</creatorcontrib><creatorcontrib>Wijngaards, G.</creatorcontrib><creatorcontrib>Grieve, J.H.K.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Booth, N.A.</au><au>Bennett, B.</au><au>Wijngaards, G.</au><au>Grieve, J.H.K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>1983-02</date><risdate>1983</risdate><volume>61</volume><issue>2</issue><spage>267</spage><epage>275</epage><pages>267-275</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>A life-long bleeding disorder is described, characterized by hemorrhage occurring after surgery, injury, or dental extraction, and finally by spontaneous intracerebral bleeding. No abnormality of platelet function or plasma coagulation was demonstrable, but grossly enhanced overall fibrinolytic activity was present. The patient had, additionally, a hyperlipidemia with gross arterial atheroma and a family history of myocardial infarction but not of any hemorrhagic disorder. Laboratory studies led to the conclusion that the enhanced fibrinolysis was due to consistently greatly raised levels of a plasma plasminogen activator physically and immunologically related to that in human tissues and blood vessel endothelium. No deficiency of any known inhibitor of fibrinolysis was detected. Free plasmin was not detectable in functional assays but continuous intravascular plasmin generation clearly occurred as evidenced by presence of plasmin-α2-antiplasmin complexes and of fibrin/fibrinogen-related antigens. Excessive production of plasminogen activator appeared to have occurred throughout life and to be independent of the hyperlipidemia. The pathologically increased fibrinolytic activity may have accounted for the complete absence of detectable thrombotic vascular occlusion at autopsy despite extensive arterial disease with severe narrowing of coronary and cerebral arteries.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>6681588</pmid><doi>10.1182/blood.V61.2.267.267</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 1983-02, Vol.61 (2), p.267-275
issn 0006-4971
1528-0020
language eng
recordid cdi_proquest_miscellaneous_80355400
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects alpha-2-Antiplasmin - immunology
Blood Coagulation Tests
Cerebral Hemorrhage - complications
Fibrinolysis
Hematoma - etiology
Hemorrhagic Disorders - complications
Hemorrhagic Disorders - etiology
Humans
Hyperlipidemias - complications
Hyperlipidemias - genetics
Immunoelectrophoresis
Male
Middle Aged
Plasminogen Activators - biosynthesis
title A New Life-Long Hemorrhagic Disorder Due to Excess Plasminogen Activator
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A56%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20New%20Life-Long%20Hemorrhagic%20Disorder%20Due%20to%20Excess%20Plasminogen%20Activator&rft.jtitle=Blood&rft.au=Booth,%20N.A.&rft.date=1983-02&rft.volume=61&rft.issue=2&rft.spage=267&rft.epage=275&rft.pages=267-275&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood.V61.2.267.267&rft_dat=%3Cproquest_cross%3E80355400%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80355400&rft_id=info:pmid/6681588&rft_els_id=S0006497120809264&rfr_iscdi=true